Trials / Terminated
TerminatedNCT01007214
Guided Biopsy for Mapping Prostate Cancer
Hybrid Imaging Technique (HIT) Guided Biopsy to Map Prostatic Adenocarcinoma in Patients Undergoing Prostatectomy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Roswell Park Cancer Institute · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the accuracy of HIT guided biopsies for mapping tumor foci with men undergoing prostatectomy.
Detailed description
The objective of this study is to determine the accuracy of HIT (Hybrid Imaging Technology) guided biopsies for mapping tumor foci with men undergoing prostatectomy. Using a prostate hybrid imaging technology (HIT) which fuses a previously obtained endorectal MR image to transrectal ultrasound (TRUS) image to allow identification and biopsy of tumors by MR imaging in real time. We hypothesis that HIT guided biopsies will accurately localize the foci of prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Prostatectomy | Elective prostatectomy |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2009-11-03
- Last updated
- 2014-02-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01007214. Inclusion in this directory is not an endorsement.